Autoreactive T cells identified in patients with anti-Jo1+ antisynthetase syndrome recognise a new epitope on histidyl t-RNA synthetase
Annals of the Rheumatic Diseases · 2026
DOI: 10.1016/j.ard.2025.09.015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of the Rheumatic Diseases, 2026. Verfasst von Angeles S Galindo-Feria und 16 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden; Center for Molecular Medicine, Stockholm, Sweden; …. Hauptthemen laut MEDLINE: Histidine-tRNA Ligase, Myositis, Epitopes, T-Lymphocyte, CD4-Positive T-Lymphocytes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hjärt-Lungfonden, Professor Nanna Svartz Foundation Fund, The Myositis Association.
Abstract (Originalsprache)
OBJECTIVES: Anti-Jo1+ antisynthetase syndrome (ASyS) is characterised by autoantibodies targeting histidyl t-RNA synthetase (HisRS), association with HLA-DRB1*03:01 and a distinct clinical phenotype including interstitial lung disease, myositis, arthritis, and mechanic's hands. Previous studies of autoreactive HisRS-specific CD4+T cells point to yet undiscovered T cell epitopes. We aimed to identify new epitopes on HisRS to investigate the presence of autoreactive T cells and their corresponding T-cell receptor (TCR) repertoire from patients with ASyS. METHODS: Peptides from HisRS N-terminal region with appropriate major histocompatibility complex (MHC) anchor residues were selected for in vitro binding assays. The peptide (HisRS41-55) with the highest HLA-DRB1*03:01 binding affinity was selected for studies with HLA-class II tetramers. Peripheral blood mononuclear cells (PBMCs) from patients with ASyS with HLA-DRB1*03:01 (n = 12) were stimulated in vitro with peptide and peptide-HLA-DRB1*03:01 tetramers were used to detect HisRS+CD4+T cells. Single TCR sequencing of captured T cells allowed analyses of the underlying TCR repertoire. RESULTS: We identified a new T cell epitope on HisRS with high affinity for HLA-DRB1*03:01. Autoreactive HisRS+CD4+T cells were detected in PBMCs of patients (n = 6/12). TCR repertoire analysis of HisRS+CD4+T cells revealed shared gene V-alpha and beta usages. Moreover, HisRS+CD4+T cells persisted after treatment in 2 patients (P2 and P4) and 2 identical T cell clones were detected between the initial and follow-up time points in 1 patient (P2). CONCLUSIONS: Autoreactive T-cells targeting a new HisRS epitope were identified indicating T cell reactivity to diverse epitopes of the HisRS protein in patients with anti-Jo1 autoantibodies. Furthermore, we demonstrated the TCR repertoire of autoreactive HisRS+CD4+T cells in patients. Persistence of these T-cells and specific clones may be contributing to disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Rheumatology, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden; Center for Molecular Medicine, Stockholm, Sweden; Department of Gastro, Dermatology and Rheumatology, Karolinska Univers…
- Division of Rheumatology, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden; Center for Molecular Medicine, Stockholm, Sweden; Department of Clinical Immunology and Rheumatology, All India Institut…
- Division of Rheumatology, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden; Center for Molecular Medicine, Stockholm, Sweden.
- Division of Rheumatology, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
- Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.
- Division of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden; Science for Life Laboratory, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Förderung
- Hjärt-Lungfonden
- Professor Nanna Svartz Foundation Fund
- The Myositis Association
- Swedish Research Council
- Swedish Rheumatism Association
- Alex and Eva Wallström Foundation for Scientific Research and Education
- Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse
- Åke Wiberg Stiftelse
Zitieren
APA
Galindo-Feria, A. S., Sharma, R. K., Dubnovitsky, A., Gerstner, C., Kozhukh, G., Van Vollenhoven, A., Boada, J. S. D., Ramsköld, D., Achour, A., Dastmalchi, M., Reid, H. H., Sandalova, T., Rossjohn, J., Chemin, K., Malmström, V., Lundberg, I. E., & Horuluoglu, B. (2026). Autoreactive T cells identified in patients with anti-Jo1+ antisynthetase syndrome recognise a new epitope on histidyl t-RNA synthetase. Annals of the Rheumatic Diseases. https://doi.org/10.1016/j.ard.2025.09.015
Vancouver
Galindo-Feria AS, Sharma RK, Dubnovitsky A, Gerstner C, Kozhukh G, Van Vollenhoven A, et al. Autoreactive T cells identified in patients with anti-Jo1+ antisynthetase syndrome recognise a new epitope on histidyl t-RNA synthetase. Annals of the Rheumatic Diseases. 2026. doi:10.1016/j.ard.2025.09.015
BibTeX
@article{GalindoFeria2026,
author = {Galindo-Feria, Angeles S and Sharma, Ravi Kumar and Dubnovitsky, Anatoly and Gerstner, Christina and Kozhukh, Genadiy and Van Vollenhoven, Annika and Boada, Juan Sebastian Diaz and Ramsköld, Daniel and Achour, Adnane and Dastmalchi, Maryam and Reid, Hugh H and Sandalova, Tatyana and Rossjohn, Jamie and Chemin, Karine and Malmström, Vivianne and Lundberg, Ingrid E and Horuluoglu, Begum},
title = {Autoreactive T cells identified in patients with anti-Jo1+ antisynthetase syndrome recognise a new epitope on histidyl t-RNA synthetase},
journal = {Annals of the Rheumatic Diseases},
year = {2026},
doi = {10.1016/j.ard.2025.09.015}
}
EUVIMED